Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Eisai Co., Ltd.
  6. News
  7. Summary
    4523   JP3160400002

EISAI CO., LTD.

(4523)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about EISAI CO., LTD.
10/17EISAI : and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Positive EU CHMP Opinions ..
AQ
10/17EISAI : and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Positive EU CHMP Opinions ..
PU
09/29EISAI CO., LTD. : Ex-dividend day for interim dividend
FA
09/28EISAI : Starts Rolling Submission To Seek US Approval For Alzheimer's Disease Therapy
MT
09/27EISAI : INITIATES ROLLING SUBMISSION TO THE U.S. FDA FOR BIOLOGICS LICENSE APPLICATION OF ..
PU
09/27BioArctic AB's partner Eisai Initiates Rolling Submission for the US FDA Biologics Lice..
CI
09/27Eisai Initiates Rolling Submission To The U.S. FDA For Biologics License Application Of..
CI
09/27EISAI : Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval
AQ
09/27EISAI : Fully Human Anti-TNFα Monoclonal Antibody HUMIRA® Obtains Additional Approva..
PU
09/22EISAI : Italy awarded highest classification at sixth annual welfare index pmi* in italy
PU
09/21EISAI : Latest Value Creation Report (Former Integrated Report)
PU
09/15EISAI : To join the global emvironmental initiative 're100'
AQ
09/14EISAI : AbbVie, Eisai, and EA Pharma Launch 'Humira Support Tool Ordering Service for Pati..
AQ
09/14EISAI : to Join The Global Environmental Initiative "RE100"
AQ
09/14EISAI : TO JOIN THE GLOBAL EMVIRONMENTAL INITIATIVE “RE100”
PU
More most relevant news
All news about EISAI CO., LTD.
10/17EISAI : and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Positive EU CHMP Opinions ..
AQ
10/17EISAI : and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Positive EU CHMP Opinions ..
PU
10/15Merck, Eisai Get CHMP Backing for Lenvima-Keytruda Combo in Two Cancers
DJ
09/29EISAI CO., LTD. : Ex-dividend day for interim dividend
FA
09/28EISAI : Starts Rolling Submission To Seek US Approval For Alzheimer's Disease Therapy
MT
09/27EISAI : INITIATES ROLLING SUBMISSION TO THE U.S. FDA FOR BIOLOGICS LICENSE APPLICATION OF ..
PU
09/27BIOARCTIC : Eisai initiates rolling submission for the US FDA Biologics license applicatio..
AQ
09/27BioArctic AB's partner Eisai Initiates Rolling Submission for the US FDA Biologics Lice..
CI
09/27Eisai Initiates Rolling Submission To The U.S. FDA For Biologics License Application Of..
CI
09/27EISAI : Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval
AQ
More news
News in other languages on EISAI CO., LTD.
10/15Merck & Co erhält EU-Zulassungsemfehlung bei Krebsmittel
09/10Le Nikkei 225 progresse de 1,3 % en raison de la perspective d'une extension des mesure..
09/07Citius Pharmaceuticals acquiert les droits de l'immunothérapie oncologique E7777 auprès..
07/16MÄRKTE ASIEN/Mehrheitlich Abgaben - Technologiewerte unter Druck
07/16Tokyo toujours perturbée par la situation sanitaire au Japon
07/16MÄRKTE ASIEN/Mehrheitlich Abgaben - Technologiewerte geben nach
06/25MÄRKTE ASIEN/Konjunkturzuversicht treibt Aktienkurse
06/25MÄRKTE ASIEN/Börsen folgen US-Vorgaben nach oben
06/24Tokyo boucle une séance prudente
06/23Tokyo mitigée en matinée
More news
Analyst Recommendations on EISAI CO., LTD.
2020Nikkei hits over 2-year high on Wall Street boost, focus on final U.S. election tally
RE
2020Biogen Alzheimer's drug closer to approval with U.S. FDA staff backing, shares jump 40%
RE
2019Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value
RE
More recommendations
Press releases
10/17EISAI : and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Positive EU CHMP Opinions ..
AQ
10/17EISAI : and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Positive EU CHMP Opinions ..
PU
09/27EISAI : INITIATES ROLLING SUBMISSION TO THE U.S. FDA FOR BIOLOGICS LICENSE APPLICATION OF ..
PU
09/27BIOARCTIC : Eisai initiates rolling submission for the US FDA Biologics license applicatio..
AQ
09/27EISAI : Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval
AQ
More press releases
Upcoming event on EISAI CO., LTD.